CRISPR Therapeutics
CRSP
$56.41
Share price
1.35%
Change (1 day)
10.43%
Change (1 year)
Market capitalization of CRISPR Therapeutics (CRSP)
Market cap: $4.78 Billion
As of April 2024 CRISPR Therapeutics has a market cap of $4.78 Billion. This makes CRISPR Therapeutics the world's 2688th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of CRISPR Therapeutics from 2016 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $4.78 B | -3.7% |
| 2023 | $4.97 B | 56.24% |
| 2022 | $3.18 B | -45.12% |
| 2021 | $5.79 B | -46.81% |
| 2020 | $10.90 B | 194.5% |
| 2019 | $3.70 B | 149.9% |
| 2018 | $1.48 B | 56.74% |
| 2017 | $0.94 B | 17.19% |
| 2016 | $0.80 B |
End of Day market cap according to different sources
On Apr 23rd, 2024 the market cap of CRISPR Therapeutics was reported to be:
$4.78 Billion
$4.78 Billion
$4.52 Billion
$4.79 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.59 B | -87.66% | 🇺🇸 USA |